Loading...
Indian Pharmaceutical Exporter · #2 for Temozolomide · $950.0K export value · DGFT Verified
Sun Pharmaceutical Industries Ltd is the #2 Indian exporter of Temozolomide with $950.0K in export value and 19 verified shipments. Sun Pharmaceutical Industries Ltd holds a 4.0% market share in Temozolomide exports across 4 countries.
| 5.8% |
| UNITED STATES | $425.1K | 56 | 5.6% |
| PHILIPPINES | $216.8K | 7 | 2.9% |
| HONG KONG | $100.0K | 2 | 1.3% |
| SINGAPORE | $35.3K | 1 | 0.5% |
Sun Pharmaceutical Industries Ltd exports Temozolomide to 8 countries. The largest destination is BELGIUM accounting for 57.2% of Sun Pharmaceutical Industries Ltd's Temozolomide shipments, followed by CANADA (18.0%) and BRAZIL (8.7%). These destinations reflect Sun Pharmaceutical Industries Ltd's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $3.8M | 184 |
| TARO PHARMACEUTICALS INC., | CANADA | $590.9K | 12 |
| YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN | BELGIUM | $493.4K | 23 |
| TARO PHARMACEUTICALS INC | CANADA | $420.0K | 9 |
| LABORATORIOS LA SANTE S.A. | COLOMBIA | $256.5K | 7 |
| TARO PHARMACEUTICALS INC. | CANADA | $250.0K | 5 |
| M/S | COLOMBIA | $239.1K | 7 |
| SUN PHARMA PHILIPPINES INC. | PHILIPPINES | $216.8K | 7 |
| M/S. SUN FARMACEUTICA DO BRAZIL LTD | BRAZIL | $204.0K | 5 |
| SUN PHARMACEUTICAL INDUSTRIES,INC. | UNITED STATES | $146.5K | 19 |
Sun Pharmaceutical Industries Ltd supplies Temozolomide to 28 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by TARO PHARMACEUTICALS INC., (CANADA) and YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN (BELGIUM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $21.7M worth of Temozolomide through 1,261 shipments from 133 suppliers to 90 countries, serving 250 buyers globally. Sun Pharmaceutical Industries Ltd contributes $950.0K to this total, accounting for 4.0% of India's Temozolomide exports. Sun Pharmaceutical Industries Ltd ships Temozolomide to 8 countries through 28 buyers.
Sun Pharmaceutical Industries Ltd's average Temozolomide shipment value is $50.0K per consignment, based on 19 shipments totaling $950.0K. The largest destination is BELGIUM (57.2% of Sun Pharmaceutical Industries Ltd's Temozolomide exports).
Sun Pharmaceutical Industries Ltd ranks #2 among 133 Indian Temozolomide exporters with a 4.0% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($14.7M), JODAS EXPOIM PRIVATE LIMITED ($1.8M), RELIANCE LIFE SCIENCES PRIVATE LIMITED ($1.7M). Sun Pharmaceutical Industries Ltd processed 19 shipments to 4 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| TARO-TEMOZOLOMIDE 20MG CAPSULES [8050 PACK X 1X5] BATCH NO. HAF0556A MFG. DT. 03/2024 EXP. DT. 02/2026 | $150.0K | 3 |
| TARO-TEMOZOLOMIDE 100MG CAPSULES [16414PACK X 1X5] BATCH NO. HAF0558A & HAF0559A MFG. DT. 02/2024 EXP. DT. 01/2026 | $150.0K | 3 |
| TARO-TEMOZOLOMIDE 140MG CAPSULES [8307 PACK X 1X5] BATCH NO. HAF0730A & HAF0731AMFG DT: 03/2024 EXP DT: 02/2026 | $150.0K | 3 |
| TEMOZOLOMIDE SUN CAP 250MG 1x5B HU PACK | $144.0K | 3 |
| TARO-TEMOZOLOMIDE 5MG CAPSULES [25247 PACK X 1X5] BATCH NO. HAF0382B MFG. DT. 02/2024 EXP. DT. 01/2026 | $140.9K | 3 |
| TEMOZOLOMIDE SUN CAP 140MG 1x5B GB PACK | $101.7K | 4 |
| TARO-TEMOZOLOMIDE 140 MG CAPSULE BATCH : | $100.0K | 2 |
| TEMOZOLOMIDE SUN CAP 100MG 1x5B HU PACK | $100.0K | 2 |
| TARO-TEMOZOLOMIDE 20MG CAPSULES (8564 PACK X 1X5) (BATCH NO. HAF3045A MFG DT. 01/2025 EXP DT. 12/2026) | $100.0K | 2 |
| TEMOZOLOMIDE SUN CAP 100MG 1x5B IT PACK | $96.8K | 4 |
Sun Pharmaceutical Industries Ltd exports 265 distinct Temozolomide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TARO-TEMOZOLOMIDE 20MG CAPSULES [8050 PACK X 1X5] BATCH NO. with 3 shipments worth $150.0K.
What Sun Pharmaceutical Industries Ltd must comply with to export Temozolomide to its top destination countries
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | JODAS EXPOIM PRIVATE LIMITED | $1.8M | 35 | 5 | $50.0K |
| 4 | RELIANCE LIFE SCIENCES PRIVATE LIMITED | $1.7M | 100 | 14 | $16.7K |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LTD ★ | $950.0K | 19 | 4 | $50.0K |
| 5 | INTAS PHARMACEUTICALS LIMITED | $825.2K | 49 | 9 | $16.8K |
| 6 | ACCURE LABS PRIVATE LIMITED | $631.0K | 45 | 1 | $14.0K |
Sun Pharmaceutical Industries Ltd ranks #2 among 133 Indian Temozolomide exporters. Average shipment value of $50.0K compared to the market average of $163.4K. The closest competitors by value are JODAS EXPOIM PRIVATE LIMITED and RELIANCE LIFE SCIENCES PRIVATE LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 247 | 19.6% |
| SAHAR AIR | 221 | 17.5% |
| NHAVA SHEVA SEA (INNSA1) | 112 | 8.9% |
| DELHI AIR CARGO ACC (INDEL4) | 99 | 7.9% |
| DELHI AIR | 72 | 5.7% |
| JNPT/ NHAVA SHEVA SEA | 53 | 4.2% |
| Bombay Air | 51 | 4.0% |
| HYDERABAD ACC (INHYD4) | 50 | 4.0% |
Latest developments and market context
Detailed market intelligence for Temozolomide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 90+ countries, 250+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sun Pharmaceutical Industries Ltd's Temozolomide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sun Pharmaceutical Industries Ltd
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Sun Pharmaceutical Industries Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Temozolomide. For current shipment-level data, contact TransData Nexus.